(Q78760398)
Statements
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors (English)
Jung-Sik Kim
Heather Crooks
Aaron Foxworth
Todd Waldman
1 December 2002
scientific article published on 01 December 2002